Meeting
2015 ASCO Annual Meeting
The impact of a Bim deletion polymorphism on the survival of patients with completely resected non-small cell lung cancer.
Authors
Jun Atsumi
Department of Thoracic and Visceral Surgery,Gunma University Graduate School of Medicine, Maebashi, Japan
Jun Atsumi , Kimihiro Shimizu , Kyoichi Kaira , Toshiteru Nagashima , Yoichi Ohtaki , Kai Obayashi , Seiichi Kakegawa , Osamu Kawashima , Mitsuhiro Kamiyoshihara , Masayuki Sugano , Izumi Takeyoshi
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers
Track
Lung Cancer
Sub Track
Local-Regional Non–Small Cell Lung Cancer
Citation
J Clin Oncol 33, 2015 (suppl; abstr 7531)
DOI
10.1200/jco.2015.33.15_suppl.7531
Abstract #
7531
Poster Bd #
278
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
Natural history of curatively resected stage IB-IIIA EGFR mutation (+) NSCLC: Clinicopathologic and molecular prognostic factors (ROOT-EGFR-ADJ).
First Author: Hyun Ae Jung
Poster
2020 ASCO Virtual Scientific Program
Clinicopathological and molecular biological characteristics of early-onset stage II/III colorectal adenocarcinoma: An analysis of 25 studies with 47,184 patients (pts) in the adjuvant colon cancer end points (ACCENT) database.
First Author: Zhaohui Jin
Poster
2019 ASCO Annual Meeting
The role of EGFR inhibitors as adjuvant therapy for EGFR mutation positive non-small cell lung cancer.
First Author: Peng Xie
Poster
2018 ASCO Annual Meeting
Immunologic and clinical implications of CD73 expression in non-small cell lung cancer (NSCLC).
First Author: Lee Chun Park